Correlation Between Purple Biotech and Lineage Cell
Can any of the company-specific risk be diversified away by investing in both Purple Biotech and Lineage Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Purple Biotech and Lineage Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Purple Biotech and Lineage Cell Therapeutics, you can compare the effects of market volatilities on Purple Biotech and Lineage Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Purple Biotech with a short position of Lineage Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Purple Biotech and Lineage Cell.
Diversification Opportunities for Purple Biotech and Lineage Cell
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Purple and Lineage is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Purple Biotech and Lineage Cell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lineage Cell Therapeutics and Purple Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Purple Biotech are associated (or correlated) with Lineage Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lineage Cell Therapeutics has no effect on the direction of Purple Biotech i.e., Purple Biotech and Lineage Cell go up and down completely randomly.
Pair Corralation between Purple Biotech and Lineage Cell
Assuming the 90 days trading horizon Purple Biotech is expected to generate 1.46 times more return on investment than Lineage Cell. However, Purple Biotech is 1.46 times more volatile than Lineage Cell Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Lineage Cell Therapeutics is currently generating about -0.24 per unit of risk. If you would invest 620.00 in Purple Biotech on September 1, 2024 and sell it today you would earn a total of 60.00 from holding Purple Biotech or generate 9.68% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Purple Biotech vs. Lineage Cell Therapeutics
Performance |
| Timeline |
| Purple Biotech |
| Lineage Cell Therapeutics |
Purple Biotech and Lineage Cell Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Purple Biotech and Lineage Cell
The main advantage of trading using opposite Purple Biotech and Lineage Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Purple Biotech position performs unexpectedly, Lineage Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lineage Cell will offset losses from the drop in Lineage Cell's long position.| Purple Biotech vs. Enlivex Therapeutics | Purple Biotech vs. Compugen | Purple Biotech vs. Purple Biotech | Purple Biotech vs. BioLine RX |
| Lineage Cell vs. Enlivex Therapeutics | Lineage Cell vs. Compugen | Lineage Cell vs. Purple Biotech | Lineage Cell vs. BioLine RX |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |